ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors OK PA On cancer Control In Disadvantaged

June 14, 1991

Report: Rising Treatment Costs Due to 340B Discounts

May 16, 2014

ASTRO Issues Statement On APBI For Breast Cancer

August 28, 2009

Study Finds Moderate Alcohol Use By Women Associated With Increased Cancer Risk

March 27, 2009

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013